Sentence examples for previous authorisation from inspiring English sources

Previous authorisation of an orphan drug by the sponsor was associated with a 16-fold increase in the chance of authorisation compared to no previous authorisation (OR = 16.2, 95% CI = 5.5 47.4), whereas previous authorisation of other drugs and previous designation of another potential orphan drug by the sponsor yielded odds ratios (95% CI) of 11.5 (3.2–42.2) and 8.0 (2.5–25.7) respectively.

Furthermore, previous authorisation outside the EU was also associated with higher chances for authorisation in the EU (OR = 4.0, 95% CI = 1.1 14.5).

These have featured in previous fast-track authorisations, but Mr Bush is dead-set against them.

"Previous reviews have found the authorisation process for banks, the cost of IT and access to branches as barriers to entry or expansion in retail banking.

Fifth, given the characteristics of the study (observational, based on retrospective real-world data), we can expect the presence of selection bias and confounding, especially in drug selection, because NOAC prescriptions are subject to prior authorisation (requiring a previous failure to keep INR in range using VKA).

He could seek authorisation from his former boss.

There are a significant number of eligibility criteria that refer to previous administration of a study agent or to the authorisation status of products that have been previously administered, which includes use of an authorised medication outside of its approved indications.

As said earlier, it must deny authorisation if the test could have been performed within previous steps.

If further previous scientific investigation is necessary at the stage of the administrative decision, the authorisation of experimental release or placing on the market must be denied.

Previous studies have shown problems in the control of these systems including deficiencies in the authorisation and review of repeats by doctors [ 16] and the issuing of medicines (which are not repeats) by receptionists [ 1].

This study was an in-depth analysis of data from a previous study on the availability of comparative information on new medicines at the time European market authorisation was granted [ 8].